Trellus Health plc

Company Profile

Company website
Health Care Providers (Health Care Services)
Trellus Health is pioneering a scientifically validated, resilience-driven personalized connected health solution which addresses the intersection of chronic disease with mental health, estimated to cost the US economy $3.7 trillion annually1. Trellus’ approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, initially focused on Inflammatory Bowel Disease (“IBD”), including Crohn's Disease and ulcerative colitis, and shortly Irritable Bowel Syndrome (“IBS”) but with potential utility and demand across many chronic conditions.

Investor Access

02 Oct
Event information

The Company will be announcing its interim results for the six months ended 30 June 2023 on Thursday 28 September 2023.

Investors can sign up to Investor Meet Company for free and add to meet Trellus Health plc via the following link (for the Investor presentation on 2 October 2023):

Monday, 2 October 2023 at 5:00pm BST

Financial Calendar
Event Date
Year End31 December
Half  Year End30 June
Preliminary Results*March / April
Interim Results*September

* Months based on previous announcements of this kind